Last edition
News about Market
Merck KGaA Acquires Bio-Techne to Expand Life Sciences Business
Merck KGaA will acquire Bio-Techne in a USD 11.3 billion deal, strengthening its leadership in life sciences and expanding capabilities across high-growth markets.
Market | 26/06/2026 | By News Bureau | 156
Advanta bioKEMIX Forms Joint Venture with Resolkem to Expand High-Purity Solvent Manufacturing
Resolkem aims to combine advanced manufacturing capabilities with global market access to strengthen supply chains for pharmaceutical, biotechnology and specialty chemical industries.
Market | 25/06/2026 | By News Bureau
The European Commission has approved Trodelvy for first-line treatment of unresectable or metastatic triple-negative breast cancer, offering a new therapeutic option for patients with one of the most aggressive forms of breast cancer.
Market | 25/06/2026 | By News Bureau | 140
Merck Partners with Versant Ventures to Launch Saturnus Bio
Merck has partnered with Versant Ventures to establish Saturnus Bio, advancing precision medicine through gene modulation technologies for rare genetic cardiomyopathies.
Market | 25/06/2026 | By News Bureau | 130
Antengene Licenses ATG-106 to K2 Therapeutics in Strategic Deal
Antengene has granted K2 Therapeutics exclusive global rights to develop and commercialise ATG-106 outside Greater China under a strategic licensing agreement that also includes an option for an undisclosed bispecific T-Cell Engager (TCE).
Market | 24/06/2026 | By News Bureau | 209
BioArctic and Lilly Sign Collaboration and Research Agreement for BrainTransporter-Based Therapy
BioArctic and Lilly have entered a research and collaboration agreement to combine a Lilly compound with BioArctic’s BrainTransporter technology. BioArctic will receive a USD 30 million upfront payment under the deal.
Market | 24/06/2026 | By News Bureau | 114
RedHill Biopharma Closes Private Placement of up to USD 19.4 Million
RedHill Biopharma has closed a private placement worth up to USD 19.4 million, including USD 6 million upfront and up to USD 13.4 million in additional proceeds from the full exercise of warrants.
Market | 23/06/2026 | By News Bureau | 118
AbbVie to Acquire Apogee Therapeutics
AbbVie plans to acquire Apogee Therapeutics, expanding its immunology portfolio with a diverse pipeline of innovative therapies for dermatologic, respiratory, inflammatory, and immune-mediated diseases.
Market | 23/06/2026 | By News Bureau | 159
Sun Pharma to Acquire Innovcare Lifesciences in INR 271 Crore Strategic Deal
Sun Pharma will acquire Innovcare Lifesciences for INR 271.2 crore, strengthening its presence in pharmaceuticals, nutraceuticals, and cosmeceuticals through the acquisition of the Mumbai-based healthcare company.
Market | 22/06/2026 | By News Bureau | 130
Oncoinvent has reached the halfway enrollment point in its Phase 2 trial of Radspherin, an experimental alpha-radiation therapy for ovarian cancer patients with peritoneal metastases, as recruitment accelerates across multiple international clinical sites.
Market | 20/06/2026 | By News Bureau | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy